The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a separate, more recent study, the same author retrospectively reviewed serious cardiovascular treatment-emergent adverse events reported in 36 tadalafil trials and found that the incidence of these events were comparable among patients taking tadalafil as needed, 3 times per week, once-daily, and placebo (Kloner et al 2006).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Kloner et al 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Prevalence and Risk Factors for Erectile Dysfunction in 2869 Men Using a Validated Questionnaire
PONHOLZER, A., TEMML, C., MOCK, K., MARSZALEK, M., OBERMAYR, R., & MADERSBACHER, S. (2005) · European Urology · doi:10.1016/j.eururo.2004.08.017 · Cited by 361
Research works printed but not linked: 16
- Carson, 2004, The efficacy and safety of tadalafil, BJU Int, 93, 1276, 10.1111/j.1464-410X.2004.04819.x · DOI
- Hellstrom, 2002, Vardenafil for treatment of men with erectile dysfunction, J Androl, 23, 763, 10.1002/j.1939-4640.2002.tb02332.x · DOI · Paper page
- Michelakis, 2003, Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension, Circulation, 108, 2066, 10.1161/01.CIR.0000099502.17776.C2 · DOI
- Burchardt, 2000, Hypertension is associated with severe erectile dysfunction, J Urol, 164, 1188, 10.1016/S0022-5347(05)67138-8 · DOI · Paper page
- Braun, 2000, Epidemiology of erectile dysfunction, Int J Impot Res, 12, 305, 10.1038/sj.ijir.3900622 · DOI
- Lewis, 2005, The efficacy of tadalafil in clinical populations, J Sex Med, 2, 517, 10.1111/j.1743-6109.2005.00068.x · DOI
- Montorsi, 2004, Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy, J Urol, 72, 1036, 10.1097/01.ju.0000136448.71773.2b · DOI · Paper page
- McMahon, 2005, Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction, J Sex Med, 2, 415, 10.1111/j.1743-6109.2005.20360.x · DOI · Paper page
- Mirone, 2005, An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction, Eur Urol, 47, 846, 10.1016/j.eururo.2005.02.019 · DOI
- 1993, Impotence, JAMA, 270, 83, 10.1001/jama.1993.03510010089036 · DOI · Paper page
- Jackson, 2004, Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events, J Sex Med, 1, 161, 10.1111/j.1743-6109.2004.04024.x · DOI
- Mittleman, 2003, Clinical trials of sildenafil citrate (Viagra®) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo, Int J Clin Pract, 57, 597, 10.1111/j.1742-1241.2003.tb10566.x · DOI
- Feldman, 2000, Erectile dysfunction and coronary risk factors, Prev Med, 30, 328, 10.1006/pmed.2000.0643 · DOI · Paper page
- Ganz, 2005, Erectile dysfunction, Am J Cardiol, 96, 8M, 10.1016/j.amjcard.2005.07.004 · DOI
- Kostis, 2005, Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference), Am J Cardiol, 96, 313, 10.1016/j.amjcard.2005.03.065 · DOI
- Mittleman, 2005, Evaluation of acute risk of myocardial infarction in men treated with sildenafil citrate, Am J Cardiol, 96, 443, 10.1016/j.amjcard.2005.03.097 · DOI
Cited by
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
Metadata
- Authors
- Kloner, R. A., Jackson, G., Hutter, A. M., Mittleman, M. A., Chan, M., Warner, M. R., Costigan, T. M., & Vail, G. M.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 97
- Issue
- 12
- Pages
- 1778-1784
- ISSN
- 0002-9149
- Cited by
- 62
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.